U.S. Markets close in 3 hrs 11 mins

Affimed (AFMD) Looks Good: Stock Moves Up 8.7% in Session

Zacks Equity Research

Affimed N.V. AFMD was a big mover last session, as the company saw its shares rise over 8% on the day. The move came on solid volume too with far more shares changing hands than in a normal session. This breaks the recent trend of the company, as the stock is now trading above the volatile price range of $2.0 to $2.18 in the past one-month time frame.

None of the estimates for this stock were revised over the last 30 days. The Zacks Consensus Estimate also remained unchanged over the same time frame. Friday’s price action is encouraging though, so make sure to keep a close watch on this firm in the near future.

Affimed currently has a Zacks Rank #3 (Hold) while its Earnings ESP is 0.00%.

Affimed N.V. Price

 

Affimed N.V. Price | Affimed N.V. Quote

A better-ranked stock worth considering from the Medical – Drugs space is Eisai Co. ESALY, sporting a Zacks Rank #1 (Strong Buy). You can see the complete list of today’s Zacks #1 Rank stocks here.

Is AFMD going up? Or down? Predict to see what others think: Up or Down

Will You Make a Fortune on the Shift to Electric Cars?

Here's another stock idea to consider. Much like petroleum 150 years ago, lithium power may soon shake the world, creating millionaires and reshaping geo-politics. Soon electric vehicles (EVs) may be cheaper than gas guzzlers. Some are already reaching 265 miles on a single charge.

With battery prices plummeting and charging stations set to multiply, one company stands out as the #1 stock to buy according to Zacks research.

It's not the one you think.

See This Ticker Free >>


Want the latest recommendations from Zacks Investment Research? Today, you can download 7 Best Stocks for the Next 30 Days. Click to get this free report
 
Eisai Co. (ESALY) : Free Stock Analysis Report
 
Affimed N.V. (AFMD) : Free Stock Analysis Report
 
To read this article on Zacks.com click here.
 
Zacks Investment Research